ロード中...

Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis

Portal hypertension (PHT) is one of the most severe consequences of liver cirrhosis. Carvedilol is a first-line pharmacological treatment of PHT. However, the antifibrogenic effects of carvedilol on liver cirrhosis and the intrinsic mechanisms underlying these effects have not been thoroughly invest...

詳細記述

保存先:
書誌詳細
出版年:Mol Med Rep
主要な著者: Ling, Liping, Li, Guangqi, Wang, Guangchuan, Meng, Dongxiao, Li, Zhen, Zhang, Chunqing
フォーマット: Artigo
言語:Inglês
出版事項: D.A. Spandidos 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625452/
https://ncbi.nlm.nih.gov/pubmed/31257490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10401
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!